SUMMARY The concentration of soluble interleukin 2 receptor (IL-2R) was determined in the serum of 54 patients with systemic lupus erythematosus (SLE) by an enzyme linked immunosorbent assay (ELISA) using two monoclonal antibodies with the IL-2R. Concentrations of soluble IL-2R in the serum of the patients with SLE (study group) were significantly higher than in 20 normal subjects (control group). The relation between concentrations of soluble IL-2R and clinical findings was investigated. The concentration of soluble IL-2R showed no particular relation with the clinical manifestations and did not correlate with the level of anti-DNA antibody or CH50. Significant correlation between the concentration of soluble IL-2R and disease activity did exist, however. Furthermore, the concentration of soluble IL-2R in some cases changed simultaneously with the disease activity. Thus the concentration of soluble IL-2R may serve as a new clinical indicator of disease activity in patients with SLE.
deficiency syndrome,12 Sezary syndrome,13 and Hodgkin's disease. 13 Thus soluble IL-2R may serve as an index of activated T cells or T cell malignancy.
In this study we determined the concentration of soluble IL-2R in the serum of patients with SLE, who were said to have activated T cells, and correlated the results obtained with the clinical findings. We found that the patients with SLE had significantly higher concentrations of soluble IL-2R than normal controls and that the concentration correlated with disease activity. Therefore, soluble IL-2R may serve as a new clinical indicator in patients with SLE.
Patients and methods

PATIENTS
Serum samples were obtained from 54 patients with SLE (50 women, four men; aged 21-49 years), according to the American Rheumatism Association criteria (1982) , and from 20 normal subjects matched in age and sex with the patients.
The patients with SLE 24 and it is known that B cell abnormality exists in patients with SLE. Therefore we cannot disregard the possibility that soluble IL-2R is also derived from B cells. As the concentration of soluble IL-2R derived from B cells is minute in comparison with that from T cells,24 however, we believe that the soluble IL-2R in the serum of patients with SLE is derived mostly from the T cells. Although the role of soluble IL-2R is not yet clear, it may be an important clue in the investigation of the pathogenesis of SLE.
